<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (RE) and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) are predisposing factors for development of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EAC), the <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> with the fastest rising incidence in the Western world </plain></SENT>
<SENT sid="1" pm="."><plain>This RE-BE-EAC cascade involves multiple host factors and consequently multiple genes </plain></SENT>
<SENT sid="2" pm="."><plain>Polymorphisms in the 3' region of myosin IXB (Myo9B) are associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory <z:e sem="disease" ids="C0017178" disease_type="Disease or Syndrome" abbrv="">gastrointestinal disorders</z:e> like <z:hpo ids='HP_0002608'>celiac disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, assuming that variation in Myo9B influences the intestinal permeability </plain></SENT>
<SENT sid="3" pm="."><plain>AIM: To determine esophageal expression and the genetic variation of the Myo9B gene in the RE-BE-EAC cascade </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: DNA from 886 Caucasian participants (198 non-reflux controls, 305 RE, 254 BE, 129 EAC) was collected for the determination of the Myo9B gene polymorphism (rs2305764) </plain></SENT>
<SENT sid="5" pm="."><plain>Esophageal Myo9B expression was determined on biopsies from <z:mpath ids='MPATH_458'>normal</z:mpath>, RE, BE and EAC epithelium </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Genotype G/G was more common in BE (p = 0.032) and EAC (p = 0.046), but not in RE (p = 0.126) compared with the control group </plain></SENT>
<SENT sid="7" pm="."><plain>Cytoplasmic Myo9B expression was determined in RE, BE and EAC, but most prominent in epithelial cells of BE and EAC </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Genetic variation of Myo9B may play a role in the etiology of BE and EAC by increasing the permeability of the epithelial barrier </plain></SENT>
</text></document>